Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Medcomm|January 3, 2022
CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancerLubaid Saleh, Caroline Wilson, Ingunn HolenActa Oncologica (Stockholm, Sweden)|November 1, 2019
CDK4/6 inhibitors in breast cancer - from <i>in vitro</i> models to clinical trialsLubaid Saleh, Caroline Wilson, Ingunn HolenJournal of Bone Oncology|January 8, 2026
Doxorubicin induces bone loss and modifies multiple cell populations <i>in vivo</i> - Implications for modelling of bone metastasisVeli Kaan Aydin, Lubaid Saleh, Penelope Dawn Ottewell, et al.Methods in Molecular Biology (Clifton, N.J.)|January 17, 2019
Isolation of Murine Hematopoietic Stem CellsJuan Bautista Menendez-Gonzalez, Lubaid Saleh, Gui Jie Feng, et al.Cancers|May 16, 2023
The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In VivoLubaid Saleh, Penelope D Ottewell, Janet E Brown, et al.Stem Cell Reports|August 6, 2019
Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid LeukemiaJuan Bautista Menendez-Gonzalez, Milica Vukovic, Ali Abdelfattah, et al.The Journal of Clinical Investigation|October 27, 2020
Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemiaAlhomidi Almotiri, Hamed Alzahrani, Juan Bautista Menendez-Gonzalez, et al.Pageof 1